TERCIT - Cell therapy and Tissue Engineering

Group type Consolidated R+D+I Group ( Experimental (laboratory) )
Associated institute Institut Universitari d'Investigacions en Ciències de la Salut (IUNICS)
AEI areas Biomedicine (BME)
2030 Goals and Targets
  • Health and well-being
    • Goal 3 - Target 4 @ Reduce mortality from non-communicable diseases
    • Goal 3 - Target b @ Support vaccine and medicine research
Areas
  • Advanced therapies: - Producing and characterising umbilical cord mesenchymal stem cells in a clean room environment (under GMP conditions) for use in cell therapy
  • Biomaterials and controlled drug release systems: - Characterising and developing bioactive coatings for use in medical devices - Characterising and developing new biomaterials for regenerative medicine including bone, cartilage, periodontal and tendon tissue - Characterising and developing new biomaterials with antibacterial properties - Characterising and developing controlled drug release systems for intraperitoneal chemotherapy delivery in advanced ovarian cancer
  • Human extracellular vesicles and substances for therapeutic use: - Cell-free regenerative medicine through the use of extracellular vesicles derived from different cell types - Developing new techniques to study, process and preserve ocular tissue - Characterising and developing demineralised bone matrix preparations from human bone for clinical use - Developing new procedures for processing human milk and studying trophic and immunological factors
  • Tissue and disease modelling: - Cultivating next-generation ovarian cancer organoids by designing extracellular matrices in combination with polymeric biomaterials - Analysing respiratory epithelium derived from induced pluripotent stem cells for disease modelling and cell therapy applications - 3D culture models to assess and develop new therapies - Establishing animal models to assess new therapies in oral tissue, skin, skeletal tissue, lungs and cancer research - Developing 3D printing technology for precision tissue engineering and disease modelling - Bioengineering tendon models to study drug development, pathology and screening
Research team
Principal investigators
Dr Monjo Cabrer, Marta (University Professor)
Main members
Members
Financed by, logos